# The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects—A Review

**Authors:** Kaj Winther

PMC · DOI: 10.3390/nu18050871 · Nutrients · 2026-03-09

## TL;DR

This review explores the clinical benefits and safety of ashwagandha, an herbal remedy used in Ayurvedic medicine, and highlights the need for more research to confirm its efficacy and safety.

## Contribution

The paper provides a critical evaluation of existing research on ashwagandha to identify knowledge gaps and guide future studies.

## Key findings

- Ashwagandha shows promise in reducing anxiety, insomnia, and stress while improving immune function.
- Few reported side effects suggest that ashwagandha may be safe for daily use.
- Regulatory agencies do not classify ashwagandha as a drug, leading to inconsistent product quality in the West.

## Abstract

Ashwagandha (Withania somnifera L.) root powder and extracts have long been used in Ayurvedic medicine to improve sleep and anxiety. Recent scientific investigations into its efficacy have shown promise for relief from anxiety, insomnia and stress and for improving the immune system. It has also been suggested that oxygen uptake in the cardiovascular system, muscle strength, cognitive function, the reproductive system and the aging process significantly benefit from ashwagandha treatment. Since the herbal remedy is taken daily by millions of people in India, China and parts of the West, it is interesting that there are very few case reports of side effects directly attributed to the treatment, suggesting that the administration of ashwagandha preparations may be safe. Currently, neither the European Medicines Agency nor the FDA considers ashwagandha as a drug or general health supplement. Therefore, ashwagandha products are marketed in the West as dietary supplements so that users may be exposed to unscrupulous vendors. In this narrative/literature review, scientific findings from basic research and human clinical trials on herbal remedies, spanning the period from 1994 to date, were critically evaluated for the purpose of highlighting knowledge gaps to provide context for new research. Such investigations will provide evidence for the efficacy and safety of ashwagandha treatment, thus making the herbal preparations more accessible to a wider audience.

## Full-text entities

- **Diseases:** anxiety (MESH:D001007), insomnia (MESH:D007319)
- **Chemicals:** oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12986965/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12986965/full.md

## References

122 references — full list in the complete paper: https://tomesphere.com/paper/PMC12986965/full.md

---
Source: https://tomesphere.com/paper/PMC12986965